p38 mapk inhibitor sb203580 (Tocris)
Structured Review
P38 Mapk Inhibitor Sb203580, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c+jun+peptide/c-JUN+peptide/ppr0949796-193-40-46
Average 93 stars, based on 28 article reviews
Images
Related Articles
Binding Assay:Article Title: miR-106a deficiency attenuates inflammation in murine IBD models. Article Snippet: .. To determine the relevance of NFκB transcription factors or AP-1 transcription factors binding to the miR-106a promoter as a result of TNFα signaling, we performed luciferase assays with the full-length miR106a construct in the presence of a NFκB inhibitor, Bay 11–7082 (10μM; Sigma-Aldrich) and an AP-1 false substrate, Luciferase:Article Title: miR-106a deficiency attenuates inflammation in murine IBD models. Article Snippet: .. To determine the relevance of NFκB transcription factors or AP-1 transcription factors binding to the miR-106a promoter as a result of TNFα signaling, we performed luciferase assays with the full-length miR106a construct in the presence of a NFκB inhibitor, Bay 11–7082 (10μM; Sigma-Aldrich) and an AP-1 false substrate, Construct:Article Title: miR-106a deficiency attenuates inflammation in murine IBD models. Article Snippet: .. To determine the relevance of NFκB transcription factors or AP-1 transcription factors binding to the miR-106a promoter as a result of TNFα signaling, we performed luciferase assays with the full-length miR106a construct in the presence of a NFκB inhibitor, Bay 11–7082 (10μM; Sigma-Aldrich) and an AP-1 false substrate, |

